The Factory Behind the Brands: Inside Korea's Cosmetic Labs

Walk through the development floor of a large Korean cosmetics manufacturer and you will not see a single brand name you recognise. There are rows of benches, homogenisers spinning pale creams, and trays of sample jars labelled with codes. Somewhere in those jars is next season's best-selling sunscreen for a brand in Los Angeles, a toner for a start-up in Seoul and a serum for a label you may already stock. The brands get the credit. The labs do much of the inventing.

This is the part of K-beauty most clients never hear about. Yet it explains a great deal about why Korean products move so fast, and about what "made in Korea" really means.

ODM and OEM, the difference

Two terms run through the industry. An OEM (original equipment manufacturer) produces a product to a formula the brand already owns. An ODM (original development manufacturer) goes further: it researches, develops and tests the formula, then manufactures it for the brand to sell under its own name. Korea's giants are ODMs. Brands arrive with a concept, a target customer and a price position. The lab arrives with a library of tested formulas, ingredient know-how and factory capacity.

Korea Biomedical Review describes Kolmar as the company that pioneered Korea's ODM model. Founded in 1990 by Yoon Dong-han with four employees, the Kolmar group became the first cosmetics ODM to be designated a large business group by Korea's Fair Trade Commission in April 2026, after its total assets passed five trillion won. Kolmar Korea reported record consolidated revenue of 2.72 trillion won for 2025.

The Cosmax machine

Its great rival, Cosmax, has become the world's largest cosmetics ODM. A Los Angeles Times report from October 2025 gives a sense of the scale. Founded in 1992, Cosmax supplies around 4,500 brands from factories in South Korea, China, the United States and Southeast Asia. It employs about 1,100 cosmetic scientists, who together release roughly 8,000 new products a year, or 80 to 100 each. The company accounts for around a quarter of all Korean cosmetics exports.

The same report explains the speed that makes K-beauty feel so relentless. Cosmax can take a product from concept to supply in three to six months, against one to three years elsewhere in the industry. It accepts orders as small as 3,000 units. Together, those two facts lower the barrier for new brands dramatically.

Why K-beauty moves so fast

Put those pieces together and the Korean model becomes clear. A small brand with a strong idea does not need its own laboratory or factory. It can brief an ODM, choose from formulas already developed and tested, and launch within months. The Los Angeles Times reported that Korea now has more than 27,000 registered cosmetics sellers, seven times as many as in 2013. More than 8,800 brands closed in a single year. The ODMs sit underneath this churn, serving whichever brands are rising.

It is paying off nationally. According to Ministry of Food and Drug Safety figures reported by Korea Biomedical Review in May 2026, Korea exported 11.4 billion dollars of cosmetics in 2025, up 11.8 per cent. That made it the world's second-largest exporter after France, shipping to 202 countries. Skincare made up almost three-quarters of the total. Cosmax and Kolmar Korea were the two largest contract manufacturers by production value.

What "made in Korea" does and doesn't tell you

Here is the nuance that matters for professionals. Two products from different brands may come out of the same factory, sometimes from closely related formula families. Conversely, one brand may use several manufacturers. The brand name on the box tells you who designed the concept and who is responsible for it. It does not always tell you who developed the formula.

"Made in Korea" does tell you something about the regulatory frame. Under Korea's Cosmetics Act, products that claim to brighten, improve wrinkles or protect against UV are classed as "functional cosmetics". Trade publication ChemLinked explains that these must go through an evaluation or reporting process with the Ministry of Food and Drug Safety before sale, backed by efficacy evidence for the claim. Everyday products without those claims follow a lighter regime.

In Great Britain, the rules are our own. Every cosmetic product placed on the market must have a UK Responsible Person, a safety assessment by a qualified assessor, a product information file and a notification through the government's SCPN service, as GOV.UK guidance sets out. Korean origin does not replace any of that.

For a closer look at why a single buzzword is never enough, see our piece on why exosomes need a specification, not a buzzword. The same principle applies to every Korean formula.